Lipidomic Profiling Reveals Phenotype‐Specific Metabolic Signatures in Obese and Hyperuricemic Children
Authors:
- 22 October 2025
- journal article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 40 (2) , e10157
Abstract
Objective: This study aims to investigate the phenotype‐specific alterations in lipid metabolism among children with obesity, hyperuricemia, and their co‐occurrence and to explore the potential associations between lipidomic profiles and clinical indicators. Methods: A nontargeted lipidomic analysis was conducted on serum samples from 100 children aged 6–18 years, categorized into control, hyperuricemia, obesity, and combined phenotype groups based on serum uric acid levels and body mass index. Metabolic network reconstruction, pathway enrichment, and correlation analyses were performed to delineate the relationships between lipid metabolic changes and clinical features. Results: The obesity group was characterized by a marked upregulation of triacylglycerols (TG). In the hyperuricemia group, membrane lipids such as phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) were predominantly downregulated, whereas phosphatidylinositol (PI) showed heterogeneous alterations. The combined phenotype exhibited more extensive disruptions across multiple metabolic pathways. Correlation analysis revealed a consistent inverse relationship between TG and glomerular filtration rate (GFR), a strong association between ceramides (Cer) and insulin metabolism, and a distinctive positive correlation between LPC and aspartate aminotransferase (AST) in the hyperuricemia group. Carnitines (CAR) showed bidirectional associations with kidney function–related parameters. Conclusion: Lipid metabolism displays phenotype‐specific regulatory patterns across distinct clinical presentations, with differential pathway involvement and functional enrichment. Key lipid species such as TG, PC, and Cer may serve as potential subtype biomarkers or therapeutic targets, offering novel insights into the early identification and precision management of metabolic disturbances in children.Keywords
This publication has 51 references indexed in Scilit:
- Mitochondrial dysfunction in metabolic syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veteransJournal of Clinical Lipidology, 2019
- Anti-Inflammatory Effects of Hypophyllanthin and Niranthin Through Downregulation of NF-κB/MAPKs/PI3K-Akt Signaling PathwaysInflammation, 2018
- l-Carnitine improves cognitive and renal functions in a rat model of chronic kidney diseasePhysiology & Behavior, 2016
- Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver diseaseMolecular Metabolism, 2016
- Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose IntoleranceCell Metabolism, 2014
- Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Oxidative stress and the etiology of insulin resistance and type 2 diabetesFree Radical Biology and Medicine, 2011
- Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitusDiabetes Research and Clinical Practice, 2009
- Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: Relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatmentAtherosclerosis, 2008